Mounjaro: Significant Weight Regain, Health Reversals After Stopping Drug

A major study warns that discontinuing the weight-loss drug Mounjaro (tirzepatide) leads to significant weight regain and reversal of crucial cardiometabolic health benefits. The SURMOUNT-4 trial found 82% of participants regained at least 25% of lost weight within a year, impacting blood pressure and cholesterol.

• Most Mounjaro users experience significant weight regain after stopping.
• 82% of participants in SURMOUNT-4 trial regained ≥25% of lost weight.
• Discontinuation also reverses improved blood pressure, cholesterol, and blood sugar.
• Continuous treatment is essential to maintain weight loss and health benefits.
• Mounjaro is India's top-selling drug, highlighting its relevance to the audience.

Read the full story on Quick Digest.